(Q34611958)

3 August 2017

1 reference

title

Drug-induced lupus: an update on its dermatologic aspects (English)

1 reference

3 August 2017

A V Marzano

1

1 reference

3 August 2017

P Vezzoli

series ordinal

2

1 reference

3 August 2017

C Crosti

series ordinal

3

1 reference

3 August 2017

publication date

1 October 2009

1 reference

3 August 2017

1 reference

3 August 2017

volume

18

1 reference

3 August 2017

issue

11

1 reference

3 August 2017

page(s)

935-940

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

3 August 2017

1 reference

Drug-induced lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Drug-induced lupus due to anti-tumor necrosis factor alpha agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Terbinafine-induced subacute cutaneous lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Bupropion-induced subacute cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Acebutolol-induced subacute cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Autoimmunity caused by disruption of central T cell tolerance. A murine model of drug-induced lupus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Disruption of positive selection of thymocytes causes autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Apoptosis in different cutaneous manifestations of lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Immunohistochemical expression of apoptotic markers in drug-induced erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Drug-induced lupus: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Minocycline induced arthritis associated with fever, livedo reticularis, and pANCA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Poikilodermatous subacute cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Human histocompatibility antigen associations in subacute cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Lupus erythematosus associated with erythema multiforme: report of two cases and review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

LUPUS ERYTHEMATOSUS AND ERYTHEMA MULTIFORME-LIKE LESIONS. A SYNDROME WITH CHARACTERISTIC IMMUNOLOGICAL ABNORMALITIES.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Drug-induced cutaneous lupus erythematosus, a distinct syndrome that is frequently unrecognized

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Drug-induced lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

Lupus erythematosus with antiphospholipid syndrome and erythema multiforme-like lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203309106176

21 January 2018

Identifiers

DOI

10.1177/0961203309106176

1 reference

3 August 2017

1 reference